These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32366290)

  • 61. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID.
    Loke XY; Imran SAM; Tye GJ; Wan Kamarul Zaman WS; Nordin F
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830303
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm.
    Kavianpour M; Saleh M; Verdi J
    Stem Cell Res Ther; 2020 Sep; 11(1):404. PubMed ID: 32948252
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19.
    Li JP; Wu KH; Chao WR; Lee YJ; Yang SF; Chao YH
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897770
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mesenchymal Stem Cell Therapy for ALI/ARDS: Therapeutic Potential and Challenges.
    Wang Z; Yu T; Hou Y; Zhou W; Ding Y; Nie H
    Curr Pharm Des; 2022; 28(27):2234-2240. PubMed ID: 35796453
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhaled Placental Mesenchymal Stromal Cell Secretome from Two- and Three-Dimensional Cell Cultures Promotes Survival and Regeneration in Acute Lung Injury Model in Mice.
    Kudinov VA; Artyushev RI; Zurina IM; Zorina ES; Lapshin RD; Snopova LB; Mukhina IV; Saburina IN
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408778
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
    Aghayan HR; Salimian F; Abedini A; Fattah Ghazi S; Yunesian M; Alavi-Moghadam S; Makarem J; Majidzadeh-A K; Hatamkhani A; Moghri M; Danesh A; Haddad-Marandi MR; Sanati H; Abbasvandi F; Arjmand B; Azimi P; Ghavamzadeh A; Sarrami-Forooshani R
    Stem Cell Res Ther; 2022 Jul; 13(1):365. PubMed ID: 35902979
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Anti-inflammatory Effects of Mesenchymal Stem Cells and their Secretomes in Pneumonia.
    Hezam K; Mo R; Wang C; Liu Y; Li Z
    Curr Pharm Biotechnol; 2022; 23(9):1153-1167. PubMed ID: 34493193
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Visualized Analyses of Investigations Upon Mesenchymal Stem/stromal Cell-based Cytotherapy and Underlying Mechanisms for COVID-19 Associated ARDS.
    Aitong W; Leisheng Z; Hao Y
    Curr Stem Cell Res Ther; 2022; 17(1):2-12. PubMed ID: 34254927
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia.
    Guo Z; Chen Y; Luo X; He X; Zhang Y; Wang J
    Crit Care; 2020 Jul; 24(1):420. PubMed ID: 32653043
    [No Abstract]   [Full Text] [Related]  

  • 70. A Bibliometric Analysis of Mesenchymal Stem Cell-Derived Exosomes in Acute Lung Injury/Acute Respiratory Distress Syndrome from 2013 to 2022.
    Zhou W; Hu S; Wu Y; Xu H; Zhu L; Deng H; Wang S; Chen Y; Zhou H; Lv X; Li Q; Yang H
    Drug Des Devel Ther; 2023; 17():2165-2181. PubMed ID: 37521034
    [TBL] [Abstract][Full Text] [Related]  

  • 71. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link?
    De Maio A; Hightower LE
    Cell Stress Chaperones; 2020 Sep; 25(5):717-720. PubMed ID: 32424591
    [No Abstract]   [Full Text] [Related]  

  • 72. Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review.
    Sadeghi B; Ringdén O; Gustafsson B; Castegren M
    Front Immunol; 2022; 13():963445. PubMed ID: 36426365
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.
    Wang W; Lei W; Jiang L; Gao S; Hu S; Zhao ZG; Niu CY; Zhao ZA
    J Transl Med; 2021 May; 19(1):198. PubMed ID: 33971907
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Mesenchymal stem cells in the fight against viruses: Face to face with the invisible enemy.
    Sleem A; Saleh F
    Curr Res Transl Med; 2020 Aug; 68(3):105-110. PubMed ID: 32616467
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extracellular vesicles in the pathogenesis and treatment of acute lung injury.
    Hu Q; Zhang S; Yang Y; Yao JQ; Tang WF; Lyon CJ; Hu TY; Wan MH
    Mil Med Res; 2022 Nov; 9(1):61. PubMed ID: 36316787
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Auxiliary role of mesenchymal stem cells as regenerative medicine soldiers to attenuate inflammatory processes of severe acute respiratory infections caused by COVID-19.
    Parhizkar Roudsari P; Alavi-Moghadam S; Payab M; Sayahpour FA; Aghayan HR; Goodarzi P; Mohamadi-Jahani F; Larijani B; Arjmand B
    Cell Tissue Bank; 2020 Sep; 21(3):405-425. PubMed ID: 32588163
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome?
    Hamdan H; Hashmi SK; Lazarus H; Gale RP; Qu W; El Fakih R
    Blood Rev; 2021 Mar; 46():100742. PubMed ID: 32854985
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mesenchymal stromal cells for sepsis and septic shock: Lessons for treatment of COVID-19.
    Laroye C; Gibot S; Huselstein C; Bensoussan D
    Stem Cells Transl Med; 2020 Dec; 9(12):1488-1494. PubMed ID: 32808462
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: a successful phase 1, control-placebo group, clinical trial.
    Kaffash Farkhad N; Sedaghat A; Reihani H; Adhami Moghadam A; Bagheri Moghadam A; Khadem Ghaebi N; Khodadoust MA; Ganjali R; Tafreshian AR; Tavakol-Afshari J
    Stem Cell Res Ther; 2022 Jun; 13(1):283. PubMed ID: 35765103
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cell-based Therapies for Acute Respiratory Distress Syndrome: Where Are We Now?
    Curley GF; O'Kane CM; McAuley DF; Matthay MA; Laffey JG
    Am J Respir Crit Care Med; 2024 Apr; 209(7):789-797. PubMed ID: 38324017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.